Centers | ||
|
|
|
Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI) | FDA Oncology Center of Excellence Project Catalyst | Therapeutic Accelerator Program (TAP) |
The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main... |
Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation |
Test |
Partnerships |
Events |
Jobs |
GIBH/CWHM MalariaGIBH is a medical research institute affiliated with the Chinese Academy of Sciences. CWHM has been collaborating with GIBH scientists since 2010 on a project to discover and develop new medicines for malaria. View all Bayer and UCSF Enter into a 10year Research & Development PartnershipBayer and University of California, San Francisco (UCSF) have signed a 10year master research and development agreement. The agreement provides a broad template for collaboration between the two groups around common areas of research interest... View all GSK and Yale to partner on drug discovery developmentGlaxoSmithKline (GSK) and Yale University will partner to design a new class of molecules to target disease-causing proteins. This is the latest in a string of deals between Yale’s academic researchers and global pharmaceutical companies. View all |
No EVENTS for listing |
No Job Posts |
